Single Cell Analysis Transcriptomics Market
PUBLISHED: 2025 ID: SMRC28353
SHARE
SHARE

Single Cell Analysis Transcriptomics Market

Single-Cell Analysis Transcriptomics Market Forecasts to 2030 - Global Analysis By Product (Instruments and Consumables), Analysis Type (Gene Expression Profiling, Epigenomics, Metabolomics, Proteomics and Other Analysis Types), Sample Type, Workflow Stage, Technology, Application, End User and By Geography

4.9 (91 reviews)
4.9 (91 reviews)
Published: 2025 ID: SMRC28353

This report covers the impact of COVID-19 on this global market
Loading...

Years Covered

2022-2030

Estimated Year Value (2024)

US $5.22 BN

Projected Year Value (2030)

US $16.01 BN

CAGR (2024 - 2030)

20.5%

Regions Covered

North America, Europe, Asia Pacific, South America, and Middle East & Africa

Countries Covered

US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa

Largest Market

Asia Pacific

Highest Growing Market

North America


According to Stratistics MRC, the Global Single-Cell Analysis Transcriptomics Market is accounted for $5.22 billion in 2024 and is expected to reach $16.01 billion by 2030 growing at a CAGR of 20.5% during the forecast period. Single-cell analysis transcriptomics is a cutting-edge approach to studying gene expression at the individual cell level. It enables the discovery of rare cell types, cell states, and dynamic processes such as differentiation. By using various technologies, researchers can uncover critical insights into development, disease mechanisms, and therapeutic targets, offering unprecedented precision in understanding complex biological systems at a single-cell resolution.

According to the American Cancer Society report, in 2022, there were an estimated 1.9 million new cancer cases diagnosed and 609,360 cancer deaths in the U.S.

Market Dynamics: 

Driver: 

Rising demand for precision medicine

As precision medicine focuses on tailoring treatments based on individual genetic and molecular profiles, single-cell transcriptomics provides critical insights into cellular heterogeneity, enabling researchers to understand how diseases manifest at the cellular level. By analyzing gene expression at single-cell resolution, this technology helps identify rare cell populations, disease biomarkers, and therapeutic targets, advancing personalized treatment strategies. Its application in oncology, immunology, and rare diseases further fuels the market's expansion, ensuring more accurate diagnostics and treatment options, which boosts demand in the healthcare sector.

Restraint:

Complexity of data analysis

The complexity of data analysis in single-cell analysis transcriptomics arises from the large volume of data generated, which requires sophisticated computational methods to interpret. Variability between cells, dropout events, and noise further complicate the process. Researchers must handle data integration, clustering, and interpretation across diverse samples, demanding advanced bioinformatics expertise. The need for specialized tools and high-performance computing infrastructure adds to the challenge. This complexity thereby slowdowns widespread adoption of single-cell technologies

Opportunity:

Growing investments in genomics research

Increased funding from governments, private organizations, and venture capital firms supports the development of more affordable, precise, and scalable single-cell technologies. This investment enables better understanding of complex biological processes, such as gene expression, differentiation, and disease mechanisms. As a result, it accelerates the adoption of single-cell transcriptomics in diverse fields, including cancer research, immunology, and regenerative medicine. Moreover, it fosters collaborations between research institutions, biotechnology companies, and contract research organizations, further advancing the market's growth and application.

Threat:

Ethical concerns

Ethical concerns in single-cell analysis transcriptomics arise mainly from the use of human tissues, especially for research involving sensitive conditions like genetic diseases, cancer, and reproductive health. Issues like consent, privacy, and the potential for misuse of genetic data create regulatory challenges. The ethical complexity of handling personal and identifiable data also raises concerns about data security. These factors can slow market growth by increasing the costs and time required to obtain ethical approvals, limit the scope of research, and deter collaboration between institutions and industry players.

Covid-19 Impact

The covid-19 pandemic accelerated the adoption of single-cell analysis transcriptomics, driving demand for advanced tools to study viral-host interactions and immune responses at cellular resolution. However, the market faced challenges such as disrupted supply chains, delayed research projects, and reduced funding for non-covid studies. Despite these setbacks, the pandemic underscored the critical role of single-cell technologies in addressing global health challenges, fostering long-term market growth.

The cancer genomics segment is expected to be the largest during the forecast period

The cancer genomics segment is predicted to secure the largest market share throughout the forecast period. Single-cell analysis transcriptomics is revolutionizing cancer genomics by providing unparalleled insights into tumor heterogeneity, clonal evolution, and the tumor microenvironment. This approach identifies rare cancer cell subpopulations, tracks disease progression, and uncovers mechanisms of therapy resistance. This precision enhances understanding of cancer biology, paving the way for personalized and targeted therapeutic interventions.

The contract research organizations (CROs) segment is expected to have the highest CAGR during the forecast period

The contract research organizations (CROs) segment is anticipated to witness the highest CAGR during the forecast period. CROs are increasingly leveraging single-cell analysis transcriptomics to support drug discovery and development. This technology aids in identifying molecular targets, understanding disease mechanisms, and evaluating drug efficacy at a cellular resolution. By offering expertise in bioinformatics and advanced platforms, CROs ensure high-quality results, facilitating the development of precision medicines.

Region with largest share:

Asia Pacific is expected to register the largest market share during the forecast period fuelled by increasing investments in genomics research, government initiatives to advance healthcare, and the rising adoption of precision medicine. Countries like China, Japan, and India are leading the region with growing research infrastructure and collaborations between academia and industry. Additionally, the high prevalence of chronic diseases and cancer drives the demand for advanced transcriptomic tools. The region presents immense potential for technological advancements and market expansion.

Region with highest CAGR:

North America is expected to witness the highest CAGR over the forecast period driven by robust research infrastructure, high adoption of advanced genomic technologies, and strong government funding for precision medicine and genomics. The U.S. leads the region with extensive research activities in cancer, immunology, and neurobiology, supported by key players and academic institutions. Canada is also emerging as a significant contributor with growing investments in biotechnology. The presence of advanced bioinformatics tools and skilled professionals further accelerates market growth. 

Key players in the market

Some of the key players profiled in the Single-Cell Analysis Transcriptomics Market include Thermo Fisher Scientific, Bio-Rad Laboratories, Becton, Dickinson and Company, QIAGEN N.V., Illumina Inc., PerkinElmer Inc., Agilent Technologies, Pacific Biosciences, Sartorius AG, Promega Corporation, Luminex Corporation, Merck KGaA, Zephyrus Biosciences, Miltenyi Biotec, Oxford Nanopore Technologies, Novogene Corporation, Fluidigm Corporation, Cell Signaling Technology Inc., 10x Genomics and NanoString Technologies.

Key Developments:

In October 2024, Cell Signaling Technology (CST) has announced the launch of InTraSeq™ Single Cell Analysis Reagents, a reliable, efficient and convenient way to simultaneously detect and study intracellular proteins and the transcriptome in a single-cell experiment, while guaranteeing a robust RNA signal.

In June 2024, Bio-Rad Laboratories, Inc. launched the ddSEQTM Single-Cell 3' RNA-Seq Kit and complementary Omnition v1.1 analysis software for single-cell transcriptome and gene expression research. Designed to be run on Bio-Rad’s droplet-based single-cell isolation system, the ddSEQ Cell Isolator, the ddSEQ Single-Cell 3' RNA-Seq Kit delivers high-quality single-cell 3' RNA-Seq libraries in a fast, efficient, and affordable workflow, allowing researchers to easily conduct single-cell gene expression and regulation analyses.

Products Covered:
• Instruments
• Consumables

Analysis Types Covered:
• Gene Expression Profiling
• Epigenomics
• Metabolomics
• Proteomics
• Other Analysis Types

Sample Types Covered:
• Human Cells
• Animal Cells
• Microbial Cells
• Plant Cells
• Other Sample Types

Workflow Stages Covered:
• Sample Preparation
• Sample Isolation
• Data Analysis
• Data Interpretation
• Other Workflow Stages

Technologies Covered:
• Next-Generation Sequencing (NGS)
• Polymerase Chain Reaction (PCR)
• Microarrays
• Single-Cell RNA Sequencing (scRNA-Seq)
• In Situ Hybridization (ISH)
• Other Technologies

Applications Covered:
• Cancer Genomics
• Neurology
• Immunology
• Stem Cell Research
• Disease Diagnosis
• Personalized Medicine
• Biomarker Discovery
• Other Applications

End Users Covered:
• Academic & Research Institutions
• Pharmaceutical & Biotechnology Companies
• Hospitals & Diagnostic Laboratories
• Contract Research Organizations (CROs)
• Other End Users

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan        
o China        
o India        
o Australia  
o New Zealand
o South Korea
o Rest of Asia Pacific    
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa 
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings: 
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary              
                
2 Preface
              
 2.1 Abstract              
 2.2 Stake Holders             
 2.3 Research Scope             
 2.4 Research Methodology            
  2.4.1 Data Mining            
  2.4.2 Data Analysis            
  2.4.3 Data Validation            
  2.4.4 Research Approach            
 2.5 Research Sources             
  2.5.1 Primary Research Sources           
  2.5.2 Secondary Research Sources           
  2.5.3 Assumptions            
                
3 Market Trend Analysis             
 3.1 Introduction             
 3.2 Drivers              
 3.3 Restraints             
 3.4 Opportunities             
 3.5 Threats              
 3.6 Product Analysis             
 3.7 Technology Analysis            
 3.8 Application Analysis            
 3.9 End User Analysis             
 3.10 Emerging Markets             
 3.11 Impact of Covid-19             
                
4 Porters Five Force Analysis             
 4.1 Bargaining power of suppliers            
 4.2 Bargaining power of buyers            
 4.3 Threat of substitutes            
 4.4 Threat of new entrants            
 4.5 Competitive rivalry             
                
5 Global Single-Cell Analysis Transcriptomics Market, By Product         
 5.1 Introduction             
 5.2 Instruments             
  5.2.1 Sequencers            
  5.2.2 Flow Cytometers            
  5.2.3 Microscopes            
 5.3 Consumables             
  5.3.1 Reagents & Kits            
  5.3.2 Microplates            
  5.3.3 Beads             
                
6 Global Single-Cell Analysis Transcriptomics Market, By Analysis Type         
 6.1 Introduction             
 6.2 Gene Expression Profiling            
 6.3 Epigenomics             
 6.4 Metabolomics             
 6.5 Proteomics             
 6.6 Other Analysis Types            
                
7 Global Single-Cell Analysis Transcriptomics Market, By Sample Type         
 7.1 Introduction             
 7.2 Human Cells             
 7.3 Animal Cells             
 7.4 Microbial Cells             
 7.5 Plant Cells             
 7.6 Other Sample Types            
                
8 Global Single-Cell Analysis Transcriptomics Market, By Workflow Stage         
 8.1 Introduction             
 8.2 Sample Preparation             
 8.3 Sample Isolation             
 8.4 Data Analysis             
 8.5 Data Interpretation             
 8.6 Other Workflow Stages            
                
9 Global Single-Cell Analysis Transcriptomics Market, By Technology         
 9.1 Introduction             
 9.2 Next-Generation Sequencing (NGS)           
 9.3 Polymerase Chain Reaction (PCR)           
 9.4 Microarrays             
 9.5 Single-Cell RNA Sequencing (scRNA-Seq)          
 9.6 In Situ Hybridization (ISH)            
 9.7 Other Technologies             
                
10 Global Single-Cell Analysis Transcriptomics Market, By Application         
 10.1 Introduction             
 10.2 Cancer Genomics             
 10.3 Neurology             
 10.4 Immunology             
 10.5 Stem Cell Research             
 10.6 Disease Diagnosis             
 10.7 Personalized Medicine            
 10.8 Biomarker Discovery            
 10.9 Other Applications             
                
11 Global Single-Cell Analysis Transcriptomics Market, By End User         
 11.1 Introduction             
 11.2 Academic & Research Institutions           
 11.3 Pharmaceutical & Biotechnology Companies          
 11.4 Hospitals & Diagnostic Laboratories           
 11.5 Contract Research Organizations (CROs)           
 11.6 Other End Users             
                
12 Global Single-Cell Analysis Transcriptomics Market, By Geography         
 12.1 Introduction             
 12.2 North America             
  12.2.1 US             
  12.2.2 Canada             
  12.2.3 Mexico             
 12.3 Europe              
  12.3.1 Germany             
  12.3.2 UK             
  12.3.3 Italy             
  12.3.4 France             
  12.3.5 Spain             
  12.3.6 Rest of Europe            
 12.4 Asia Pacific             
  12.4.1 Japan             
  12.4.2 China             
  12.4.3 India             
  12.4.4 Australia             
  12.4.5 New Zealand            
  12.4.6 South Korea            
  12.4.7 Rest of Asia Pacific            
 12.5 South America             
  12.5.1 Argentina            
  12.5.2 Brazil             
  12.5.3 Chile             
  12.5.4 Rest of South America           
 12.6 Middle East & Africa            
  12.6.1 Saudi Arabia            
  12.6.2 UAE             
  12.6.3 Qatar             
  12.6.4 South Africa            
  12.6.5 Rest of Middle East & Africa           
                
13 Key Developments              
 13.1 Agreements, Partnerships, Collaborations and Joint Ventures         
 13.2 Acquisitions & Mergers            
 13.3 New Product Launch            
 13.4 Expansions             
 13.5 Other Key Strategies            
                
14 Company Profiling              
 14.1 Thermo Fisher Scientific            
 14.2 Bio-Rad Laboratories            
 14.3 Becton, Dickinson and Company           
 14.4 QIAGEN N.V.             
 14.5 Illumina Inc.             
 14.6 PerkinElmer Inc.             
 14.7 Agilent Technologies            
 14.8 Pacific Biosciences             
 14.9 Sartorius AG             
 14.10 Promega Corporation            
 14.11 Luminex Corporation            
 14.12 Merck KGaA             
 14.13 Zephyrus Biosciences            
 14.14 Miltenyi Biotec             
 14.15 Oxford Nanopore Technologies           
 14.16 Novogene Corporation            
 14.17 Fluidigm Corporation            
 14.18 Cell Signaling Technology Inc.            
 14.19 10x Genomics             
 14.20 NanoString Technologies            
                
List of Tables               
1 Global Single-Cell Analysis Transcriptomics Market Outlook, By Region (2022-2030) ($MN)       
2 Global Single-Cell Analysis Transcriptomics Market Outlook, By Product (2022-2030) ($MN)       
3 Global Single-Cell Analysis Transcriptomics Market Outlook, By Instruments (2022-2030) ($MN)      
4 Global Single-Cell Analysis Transcriptomics Market Outlook, By Sequencers (2022-2030) ($MN)      
5 Global Single-Cell Analysis Transcriptomics Market Outlook, By Flow Cytometers (2022-2030) ($MN)      
6 Global Single-Cell Analysis Transcriptomics Market Outlook, By Microscopes (2022-2030) ($MN)      
7 Global Single-Cell Analysis Transcriptomics Market Outlook, By Consumables (2022-2030) ($MN)      
8 Global Single-Cell Analysis Transcriptomics Market Outlook, By Reagents & Kits (2022-2030) ($MN)      
9 Global Single-Cell Analysis Transcriptomics Market Outlook, By Microplates (2022-2030) ($MN)      
10 Global Single-Cell Analysis Transcriptomics Market Outlook, By Beads (2022-2030) ($MN)       
11 Global Single-Cell Analysis Transcriptomics Market Outlook, By Analysis Type (2022-2030) ($MN)      
12 Global Single-Cell Analysis Transcriptomics Market Outlook, By Gene Expression Profiling (2022-2030) ($MN)     
13 Global Single-Cell Analysis Transcriptomics Market Outlook, By Epigenomics (2022-2030) ($MN)      
14 Global Single-Cell Analysis Transcriptomics Market Outlook, By Metabolomics (2022-2030) ($MN)      
15 Global Single-Cell Analysis Transcriptomics Market Outlook, By Proteomics (2022-2030) ($MN)      
16 Global Single-Cell Analysis Transcriptomics Market Outlook, By Other Analysis Types (2022-2030) ($MN)      
17 Global Single-Cell Analysis Transcriptomics Market Outlook, By Sample Type (2022-2030) ($MN)      
18 Global Single-Cell Analysis Transcriptomics Market Outlook, By Human Cells (2022-2030) ($MN)      
19 Global Single-Cell Analysis Transcriptomics Market Outlook, By Animal Cells (2022-2030) ($MN)      
20 Global Single-Cell Analysis Transcriptomics Market Outlook, By Microbial Cells (2022-2030) ($MN)      
21 Global Single-Cell Analysis Transcriptomics Market Outlook, By Plant Cells (2022-2030) ($MN)       
22 Global Single-Cell Analysis Transcriptomics Market Outlook, By Other Sample Types (2022-2030) ($MN)      
23 Global Single-Cell Analysis Transcriptomics Market Outlook, By Workflow Stage (2022-2030) ($MN)      
24 Global Single-Cell Analysis Transcriptomics Market Outlook, By Sample Preparation (2022-2030) ($MN)      
25 Global Single-Cell Analysis Transcriptomics Market Outlook, By Sample Isolation (2022-2030) ($MN)      
26 Global Single-Cell Analysis Transcriptomics Market Outlook, By Data Analysis (2022-2030) ($MN)      
27 Global Single-Cell Analysis Transcriptomics Market Outlook, By Data Interpretation (2022-2030) ($MN)      
28 Global Single-Cell Analysis Transcriptomics Market Outlook, By Other Workflow Stages (2022-2030) ($MN)     
29 Global Single-Cell Analysis Transcriptomics Market Outlook, By Technology (2022-2030) ($MN)      
30 Global Single-Cell Analysis Transcriptomics Market Outlook, By Next-Generation Sequencing (NGS) (2022-2030) ($MN)    
31 Global Single-Cell Analysis Transcriptomics Market Outlook, By Polymerase Chain Reaction (PCR) (2022-2030) ($MN)    
32 Global Single-Cell Analysis Transcriptomics Market Outlook, By Microarrays (2022-2030) ($MN)      
33 Global Single-Cell Analysis Transcriptomics Market Outlook, By Single-Cell RNA Sequencing (scRNA-Seq) (2022-2030) ($MN)    
34 Global Single-Cell Analysis Transcriptomics Market Outlook, By In Situ Hybridization (ISH) (2022-2030) ($MN)     
35 Global Single-Cell Analysis Transcriptomics Market Outlook, By Other Technologies (2022-2030) ($MN)      
36 Global Single-Cell Analysis Transcriptomics Market Outlook, By Application (2022-2030) ($MN)      
37 Global Single-Cell Analysis Transcriptomics Market Outlook, By Cancer Genomics (2022-2030) ($MN)      
38 Global Single-Cell Analysis Transcriptomics Market Outlook, By Neurology (2022-2030) ($MN)       
39 Global Single-Cell Analysis Transcriptomics Market Outlook, By Immunology (2022-2030) ($MN)      
40 Global Single-Cell Analysis Transcriptomics Market Outlook, By Stem Cell Research (2022-2030) ($MN)      
41 Global Single-Cell Analysis Transcriptomics Market Outlook, By Disease Diagnosis (2022-2030) ($MN)      
42 Global Single-Cell Analysis Transcriptomics Market Outlook, By Personalized Medicine (2022-2030) ($MN)     
43 Global Single-Cell Analysis Transcriptomics Market Outlook, By Biomarker Discovery (2022-2030) ($MN)      
44 Global Single-Cell Analysis Transcriptomics Market Outlook, By Other Applications (2022-2030) ($MN)      
45 Global Single-Cell Analysis Transcriptomics Market Outlook, By End User (2022-2030) ($MN)       
46 Global Single-Cell Analysis Transcriptomics Market Outlook, By Academic & Research Institutions (2022-2030) ($MN)    
47 Global Single-Cell Analysis Transcriptomics Market Outlook, By Pharmaceutical & Biotechnology Companies (2022-2030) ($MN)   
48 Global Single-Cell Analysis Transcriptomics Market Outlook, By Hospitals & Diagnostic Laboratories (2022-2030) ($MN)    
49 Global Single-Cell Analysis Transcriptomics Market Outlook, By Contract Research Organizations (CROs) (2022-2030) ($MN)    
50 Global Single-Cell Analysis Transcriptomics Market Outlook, By Other End Users (2022-2030) ($MN)      
                
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.  

List of Figures

RESEARCH METHODOLOGY


Research Methodology

We at Stratistics opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.

Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.

Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.

Data Mining

The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.

Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.

Data Analysis

From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:

  • Product Lifecycle Analysis
  • Competitor analysis
  • Risk analysis
  • Porters Analysis
  • PESTEL Analysis
  • SWOT Analysis

The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.


Data Validation

The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.

We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants

Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.


For more details about research methodology, kindly write to us at info@strategymrc.com

Frequently Asked Questions

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

Request Customization

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials